{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T09:51:57Z","timestamp":1782813117506,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.vaccine.2022.09.048","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T22:04:36Z","timestamp":1664834676000},"page":"6520-6527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["FHUSPA2\/10 is a bactericidal monoclonal antibody targeting multiple repeated sequences of Moraxella catarrhalis UspA2"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9471-0254","authenticated-orcid":false,"given":"Danilo","family":"Donnarumma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0466-6059","authenticated-orcid":false,"given":"Fabiola","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Ysebaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Hermand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ferlenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immaculada","family":"Margarit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rossi Paccani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-1160","authenticated-orcid":false,"given":"Maria","family":"Scarselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4567-110X","authenticated-orcid":false,"given":"Nathalie","family":"Norais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9859","key":"10.1016\/j.vaccine.2022.09.048_b0005","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.048_b0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12931-017-0548-3","article-title":"Understanding the impact of symptoms on the burden of COPD","volume":"18","author":"Miravitlles","year":"2017","journal-title":"Respir Res"},{"issue":"14","key":"10.1016\/j.vaccine.2022.09.048_b0015","first-page":"937","article-title":"An overview of Global Strategy for the Diagnosis, (GOLD) (revised 2011)","volume":"92","author":"Vestbo","year":"2012","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"22","key":"10.1016\/j.vaccine.2022.09.048_b0020","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2022.09.048_b0025","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.200709-1413OC","article-title":"Pseudomonas aeruginosa in chronic obstructive pulmonary disease","volume":"177","author":"Murphy","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.048_b0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1164\/rccm.200412-1747OC","article-title":"Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response","volume":"172","author":"Murphy","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.vaccine.2022.09.048_b0035","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1056\/NEJMoa012561","article-title":"New strains of bacteria and exacerbations of chronic obstructive pulmonary disease","volume":"347","author":"Sethi","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.048_b0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1086\/599375","article-title":"Moraxella catarrhalis, a human respiratory tract pathogen","volume":"49","author":"Murphy","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"Suppl S2","key":"10.1016\/j.vaccine.2022.09.048_b0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/jac\/dkf506","article-title":"Dynamics of nasopharyngeal colonization by potential respiratory pathogens","volume":"50","author":"Garcia-Rodriguez","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.vaccine.2022.09.048_b0050","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1080\/21645515.2017.1356951","article-title":"A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges","volume":"13","author":"Perez","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"16","key":"10.1016\/j.vaccine.2022.09.048_b0055","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1002\/1873-3468.13758","article-title":"Complement evasion by the human respiratory tract pathogens Haemophilus influenzae and Moraxella catarrhalis","volume":"594","author":"Riesbeck","year":"2020","journal-title":"FEBS Lett"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2022.09.048_b0060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/1040841X.2019.1660616","article-title":"Otitis media pathogens - A life entrapped in biofilm communities","volume":"45","author":"Silva","year":"2019","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.048_b0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/dkp401","article-title":"bro {beta}-lactamase and antibiotic resistances in a global cross-sectional study of Moraxella catarrhalis from children and adults","volume":"65","author":"Khan","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.vaccine.2022.09.048_b0070","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1099\/mic.0.000523","article-title":"Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development","volume":"163","author":"Blakeway","year":"2017","journal-title":"Microbiology (Reading)"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.048_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1517\/14728222.2015.1081686","article-title":"Vaccine targets against Moraxella catarrhalis","volume":"20","author":"Ren","year":"2016","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.048_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00430-019-00649-y","article-title":"Immunogenicity of trimeric autotransporter adhesins and their potential as vaccine targets","volume":"209","author":"Thibau","year":"2020","journal-title":"Med Microbiol Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2022.09.048_b0085","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1128\/JB.182.5.1364-1373.2000","article-title":"The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro","volume":"182","author":"Lafontaine","year":"2000","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.048_b0090","first-page":"61","article-title":"uspA1 of Moraxella catarrhalis clinical isolates in Japan and its relationship with adherence to HEp-2 cells","volume":"56","author":"Qiu","year":"2009","journal-title":"J Med Dent Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.048_b0095","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/IAI.74.3.1588-1596.2006","article-title":"Biofilm formation by Moraxella catarrhalis in vitro: roles of the UspA1 adhesin and the Hag hemagglutinin","volume":"74","author":"Pearson","year":"2006","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.048_b0100","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1128\/IAI.74.3.1597-1611.2006","article-title":"Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade","volume":"74","author":"Attia","year":"2006","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.048_b0105","doi-asserted-by":"crossref","first-page":"445","DOI":"10.18388\/abp.2006_3315","article-title":"MID and UspA1\/A2 of the human respiratory pathogen Moraxella catarrhalis, and interactions with the human host as basis for vaccine development","volume":"53","author":"Riesbeck","year":"2006","journal-title":"Acta Biochim Pol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.09.048_b0110","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.4049\/jimmunol.175.6.3628","article-title":"Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity","volume":"175","author":"Nordstr\u00f6m","year":"2005","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.09.048_b0115","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.4049\/jimmunol.173.7.4598","article-title":"The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2","volume":"173","author":"Nordstr\u00f6m","year":"2004","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2022.09.048_b0120","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1128\/iai.65.11.4367-4377.1997","article-title":"A protective epitope of Moraxella catarrhalis is encoded by two different genes","volume":"65","author":"Aebi","year":"1997","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.048_b0125","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/infdis\/170.4.867","article-title":"A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies","volume":"170","author":"Helminen","year":"1994","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.048_b0130","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1128\/IAI.66.9.4374-4381.1998","article-title":"Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope","volume":"66","author":"Sansonetti","year":"1998","journal-title":"Infect Immun"},{"issue":"39","key":"10.1016\/j.vaccine.2022.09.048_b0135","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1016\/j.vaccine.2021.08.002","article-title":"UspA2 is a cross-protective Moraxella catarrhalis vaccine antigen","volume":"39","author":"Ysebaert","year":"2021","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.048_b0140","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1128\/IAI.67.3.1310-1316.1999","article-title":"The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children","volume":"67","author":"Sansonetti","year":"1999","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2022.09.048_b0145","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.4049\/jimmunol.1002621","article-title":"Immune evasion of Moraxella catarrhalis involves ubiquitous surface protein A-dependent C3d binding","volume":"186","author":"Hallstr\u00f6m","year":"2011","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.048_b0150","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1128\/IAI.00310-15","article-title":"Moraxella catarrhalis Binds Plasminogen To Evade Host Innate Immunity","volume":"83","author":"Singh","year":"2015","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2022.09.048_b0155","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1165\/rcmb.2007-0289OC","article-title":"Moraxella-dependent alpha 1-antichymotrypsin neutralization: a unique virulence mechanism","volume":"38","author":"Manolov","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.048_b0160","doi-asserted-by":"crossref","first-page":"e45452","DOI":"10.1371\/journal.pone.0045452","article-title":"A novel group of Moraxella catarrhalis UspA proteins mediates cellular adhesion via CEACAMs and vitronectin","volume":"7","author":"Hill","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.048_b0165","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/505581","article-title":"The respiratory pathogen moraxella catarrhalis binds to laminin via ubiquitous surface proteins A1 and A2","volume":"194","author":"Tan","year":"2006","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.048_b0170","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00066-16","article-title":"The respiratory pathogen moraxella catarrhalis targets collagen for maximal adherence to host tissues","volume":"7","author":"Singh","year":"2016","journal-title":"mBio"},{"issue":"10","key":"10.1016\/j.vaccine.2022.09.048_b0175","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/thoraxjnl-2016-209023","article-title":"A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD","volume":"72","author":"Wilkinson","year":"2017","journal-title":"Thorax"},{"issue":"40","key":"10.1016\/j.vaccine.2022.09.048_b0180","doi-asserted-by":"crossref","first-page":"16950","DOI":"10.1073\/pnas.0907256106","article-title":"A coiled-coil motif that sequesters ions to the hydrophobic core","volume":"106","author":"Hartmann","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.048_b0185","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/IAI.00367-08","article-title":"Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein","volume":"76","author":"Beernink","year":"2008","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.048_b0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-22057-7","article-title":"Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes","volume":"8","author":"Giuliani","year":"2018","journal-title":"Sci Rep"},{"issue":"24","key":"10.1016\/j.vaccine.2022.09.048_b0195","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1042\/BCJ20160806","article-title":"Neisseria meningitidis factor H-binding protein bound to monoclonal antibody JAR5: implications for antibody synergy","volume":"473","author":"Malito","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2022.09.048_b0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/s42003-019-0493-4","article-title":"Structural basis for cooperativity of human monoclonal antibodies to meningococcal factor H-binding protein","volume":"2","author":"Peschiera","year":"2019","journal-title":"Commun Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.09.048_b0205","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1086\/432759","article-title":"The respiratory pathogen Moraxella catarrhalis adheres to epithelial cells by interacting with fibronectin through ubiquitous surface proteins A1 and A2","volume":"192","author":"Tan","year":"2005","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:18:57Z","timestamp":1759403937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22011562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":41,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0264410X22011562"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.048","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FHUSPA2\/10 is a bactericidal monoclonal antibody targeting multiple repeated sequences of Moraxella catarrhalis UspA2","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}